Mercury ban will hit exporters to Europe
This article was originally published in Clinica
The European Commission's proposal to ban mercury in medical instruments sold to the general public would only impact a small number of small to medium-sized enterprises (SMEs) in the EU. But companies exporting to the EU from China, India and Japan are likely to be badly hit. That is the Commission's view, as expressed in its Impact Assessment of the proposal that it has just published (see Clinica No 1194, p 4).